SUNREST Share Price

NSE: SUNREST

S Cap

₹ 35.15

-₹2.85 (-7.5%)

Last updated 13 Aug, 2026, 11:42 IST

SUNREST Share Price Today

As of 14 Aug 2026, SUNREST share price is ₹35.15. The stock opened at ₹37.00, compared to its previous close of ₹38.00. During today's trading session, SUNREST share price moved in the range of ₹35.15 to ₹37.00, with an average price of ₹36.08 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.66 and a high of ₹48.23. On the performance front, SUNREST share price has declined by 5.00% over the last six months and is down 33.62% on a year-on-year basis.

₹35.15

7.50% down today

₹37.00

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 7.64 % in last 1 month

SUNREST Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹3,45,965-₹1,54,035 (-30.81%)

3 Year

₹2,47,535-₹2,52,465 (-50.49%)

5 Year

₹2,47,535-₹2,52,465 (-50.49%)

₹30.40₹45.60

Circuit Low

Circuit High

₹24.66₹48.23

52-Week Low

52-Week High

Circuit

₹30.40

₹45.60

52-week

₹24.66

₹48.23

About SUNREST

ISIN

INE0PLZ01012

Sector Market Cap

₹ 32.61 Cr

Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the business of selling healthcare products, medicines, and cosmetics. It deals in capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders, and toothpaste. The Company’s product portfolio comprises a range of drugs like Anti-Bacterial, Anti-Diarrheal, Antifungal, Anti Malerial, Anti-Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti-Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory. The Company operates in different states of India, such as Maharashtra, Gujarat, Madhya Pradesh, Odisha, and Rajasthan. The Company works on a third-party manufacturing basis or at times a purchase order basis with manufacturers of pharma products, depending upon the customer’s requirements.

SUNREST Financial Highlights

Revenue: SUNREST reported revenue of ₹73.34 crore in FY26 vs ₹33.41 crore in FY25. It showed an increase of 119.52% on a yearly basis.
Operating Profit: SUNREST reported an operating profit of ₹10.10 crore in FY26 vs ₹2.62 crore in FY25. It showed an increase of 285.50% on a year-on-year basis.
Net Profit: SUNREST reported a net profit of ₹7.99 crore in FY26 vs ₹2.01 crore in FY25. It showed an increase of 297.51% on a yearly basis.

Know more

Promoters

53.50%

FII

0.00%

Other DII

0.00%

Retail and other

46.50%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

32.61

P/E

—

P/B

—

ROE

—

D/E

0.00

ROCE

—

Div. Yield

0.00%

EPS(TTM)

7.20

Turnover

1.23

EV/EBITDA

—

Net Margin

0.00%

Op. Margin

0.00%

ROA

—

Quick Ratio

0.00

Curr. Ratio

0.00

Mkt Cap Cr

32.61

P/E

—

P/B

—

ROE

—

D/E

0.00

ROCE

—

Div. Yield

0.00%

EPS(TTM)

7.20

Turnover

1.23

EV/EBITDA

—

Net Margin

0.00%

Op. Margin

0.00%

ROA

—

Quick Ratio

0.00

Curr. Ratio

0.00

Based on fundamentals, this stock's

Performance

Excellent

Sunrest Lifescie outperforming all market indices

Earnings

Neutral

Sunrest Lifescie earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,64,271.00	38.32	5.56	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,26,843.00	77.55	13.53	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,86,000.00	86.27	22.12	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Zydus Lifesciences	1,20,099.00	26.15	4.43	18.59%	0.31	17.35%	237.30	0.08%	0.33	35.38
Cipla	1,18,071.00	35.18	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Lupin	1,03,549.00	18.65	4.61	23.76%	0.04	24.88%	659.05	0.79%	0.57	129.18
Mankind Pharma	1,00,137.00	48.43	6.14	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Dr. Reddy's Laboratories	1,00,073.00	31.44	2.63	11.07%	0.18	12.54%	377.96	0.67%	0.41	38.68
Laurus Labs	99,474.20	91.23	18.77	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	96,700.60	26.06	2.55	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

SUNREST Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2026
Revenue	33.41	73.34
Operating profit	2.62	10.1
Net profit	2.01	7.99

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹33.12	₹29.48	₹24.64	₹26.89
Other Income	₹0.00	₹0.00	₹0.03	₹0.02
Total Revenue	₹33.12	₹29.48	₹24.67	₹26.91
Total Expenses	₹30.51	₹28.89	₹21.93	₹25.86
Profit Before Tax	₹2.61	₹0.59	₹2.74	₹1.05
Tax	₹0.61	₹0.37	₹0.70	₹0.27
Profit After Tax	₹2.00	₹0.23	₹2.04	₹0.78
EPS - Basic	₹4.66	₹0.68	₹6.81	₹2.59
EPS - Diluted	₹4.66	₹0.68	₹6.81	₹2.59

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹2.61	₹0.59	₹2.74	₹1.05
Income before WC changes	₹3.00	₹0.91	₹2.93	₹1.11
Change in Assets	-₹8.87	-₹8.56	-₹3.71	-₹2.98
Change in Liabilities	₹7.77	-₹6.31	₹2.31	₹1.51
Change in WC	-₹1.09	-₹14.87	-₹1.40	-₹1.47
Cash flow from Operations	₹1.43	-₹14.80	₹1.15	-₹0.44
Cash flow from Investing	-₹1.14	-₹0.01	-₹0.03	-₹0.36
Cash flow from Financing	-₹0.30	₹14.64	-₹1.15	₹0.90
Total Cash Flow	-₹0.01	-₹0.16	-₹0.03	₹0.11
Cash (Start of the year)	₹0.29	₹0.45	₹0.48	₹0.37
Cash (End of the year)	₹0.28	₹0.29	₹0.45	₹0.48

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹6.89	₹0.32	₹0.41	₹0.50
Current Assets	₹28.26	₹24.83	₹16.30	₹12.52
Total Assets	₹35.16	₹25.16	₹16.71	₹13.02
Current Liabilities	₹14.55	₹7.51	₹11.60	₹8.86
Net Current Asset	₹13.71	₹17.32	₹4.70	₹3.67
Non-Current Liabilities	₹4.42	₹3.46	₹2.00	₹3.09
Equity Capital	₹16.19	₹14.19	₹3.11	₹1.07
Total Equity & Liabilities	₹35.16	₹25.16	₹16.71	₹13.02